Lecture Contents delivered at Koch Institute for Integrative Cancer Research, Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014 @MIT
June 16, 2014 by 2012pharmaceutical
Lecture Contents delivered at Koch Institute for Integrative Cancer Research, Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014 @MIT
Curator of Lecture Contents: Aviva Lev-Ari, PhD, RN
9:00 – 9:10 – 6/13/2014, Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer
http://pharmaceuticalintelligence.com/2014/06/10/900-910-6132-14-tyler-jacks-director-david-h-koch-institute-for-integrative-cancer/
9:10 – 9:30, 6/13/2014, Phillip Sharp “Why RNA Biology?” Phillip Sharp, PhD Institute Professor, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
http://pharmaceuticalintelligence.com/2014/06/13/910-930-6132014-phillip-sharp-why-rna-biology-phillip-sharp-phd-institute-professor-koch-institute-for-integrative-cancer-research-massachusetts-institute-of-technolog/
9:30 – 10:00, 6/13/2014, David Bartel “MicroRNAs, poly(A) tails and post-transcriptional gene regulation.”
http://pharmaceuticalintelligence.com/2014/06/13/930-1000-6132014-david-bartel-micrornas-polya-tails-and-post-transcriptional-gene-regulation/
10:00 – 10:30, 6/13/2014, Joshua Mendell “Novel microRNA functions in mammalian physiology and cancer
http://pharmaceuticalintelligence.com/2014/06/10/1000-1030-6132014-joshua-mendell-novel-microrna-functions-in-mammalian-physiology-and-cancer/
10:30 – 11:00, 6/13/2014, Sangeeta Bhatia “ Targeting siRNA delivery to tumors”
http://pharmaceuticalintelligence.com/2014/06/13/1030-1100-6132014-sangeeta-bhatia-targeting-sirna-delivery-to-tumors/
11:30 – 12:00, 6/13/2014, Daniel Anderson “Intracellular RNA delivery”
http://pharmaceuticalintelligence.com/2014/06/13/1130-1200-6132014-daniel-anderson-intracellular-rna-delivery/
12:00 – 12:30, 6/13/2014, John Maraganore “Progress in advancement of RNAi therapeutics”
http://pharmaceuticalintelligence.com/2014/06/13/1200-1230-6132014-john-maraganore-progress-in-advancement-of-rnai-therapeutics/
12:30 – 1:00, 6/13/2014, Stanley Crooke “The human RNase H1 degradasome, biological roles and toles in antisense pharmacology
http://pharmaceuticalintelligence.com/2014/06/13/1230-100-6132014-stanley-crooke-the-human-rnase-h1-degradasome-biological-roles-and-toles-in-antisense-pharmacology/
2:15 – 2:45, 6/13/2014, Jennifer Doudna “The biology of CRISPRs: from genome defense to genetic engineering”
http://pharmaceuticalintelligence.com/2014/06/13/215-245-6132014-jennifer-doudna-the-biology-of-crisprs-from-genome-defense-to-genetic-engineering/
2:45 – 3:15, 6/13/2014, Jeannie Lee “Regulatory interactions between RNA and Polycomb repressive complex 2”
http://pharmaceuticalintelligence.com/2014/06/10/245-315-2014-jeannie-lee-regulatory-interactions-between-rna-and-polycomb-repressive-complex-2/
3:15 – 3:45, 6/13/2014, Laurie Boyer “Long non-coding RNAs: molecular regulators of cell fate”
http://pharmaceuticalintelligence.com/2014/06/13/315-345-2014-laurie-boyer-long-non-coding-rnas-molecular-regulators-of-cell-fate/
3:45 – 4:15, 6/13/2014, Scott Lowe “Tumor suppressor and tumor maintenance genes”
http://pharmaceuticalintelligence.com/2014/06/13/345-415-2014-scott-lowe-tumor-suppressor-and-tumor-maintenance-genes/
4:15 -4:30, 6/13/2014, Tyler Jacks, Closing Remarks
-
-
-
Tweets via @pharma_BI
Like this:
Like Loading...
Leave a Reply